Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

BCAC – The Breast Cancer Association Consortium

The Breast Cancer Association Consortium (BCAC) is a multidisciplinary dynamic consortium formed in April 2005 and led by scientists at the University of Cambridge. It is a forum of investigators, who are interested in investigating the inherited risk of breast cancer. Many groups around the world are conducting studies with the aim of identifying genes that may be related to the risk of breast cancer. The aim of the consortium is to combine data from many studies, to provide a reliable assessment of the risks associated with these genes, and to incorporate this information to improve risk prediction models.

There are currently over 420,000 women from more than 100 studies participating in the BCAC. Each study submits information about its study subjects including demographics, clinical data, and key epidemiological risk factors.

Our group contributes two population-based case-control studies to the BCAC: the GESBC study includes approximately 700 premenopausal breast cancer cases and 1400 controls, and the MARIE study includes more than 3,800 postmenopausal breast cancer cases and over 7,300 controls.

Within the BCAC, our group coordinates the work on collating and harmonizing classical risk factor information from the studies into a central database. We also spearhead analyses of environmental risk factors and gene-environment interactions with the aim of assessing whether effects of established or suspected environmental/lifestyle risk factors for breast cancer differ according to subgroups classified according to breast cancer subtypes and/or genetic susceptibility. Knowledge about gene-environment interactions is relevant for improving individual risk assessment.

Recent funding for scientific projects in BCAC include the B-CAST project (EU Horizon2020) and CONFLUENCE (NCI Intramural Research fund). The aim of B-CAST is to develop tools to allow precise identification of individual risk of breast cancer, the subtype of cancer most likely to develop and prognosis of that particular subtype.

University of Cambridge, Karolinska Institutet, Netherlands Cancer Institute, National Cancer Institute (USA)

European Commission (COGS project 2009 - 2013, B-CAST project 2015 - 2020)
National Cancer Institute Intramural Research fund (CONFLUENCE)

to top
powered by webEdition CMS